High6.1.2, OFFICE OF THE PRESIDENT ..o C #OFFICIAL'ik

Republic of the Philippines OFFICE OF THE PRESIDENT

COMMISSION ON HIGHER EDUCATION

CHED MEMORANDUM ORDER No. )5 Series of 2021

cS7

re High6.1.2,

yo, ..o Co #OFFICIAL'ik o c.> RELEASE S Ci CHED Central Office 6 to -0 RECORDS SECTION Ci

co 'Ov Q 4ve., u.p.0‘`

SUBJECT: POLICIES, STANDARDS AND GUIDELINES FOR THE BACHELOR OF SCIENCE IN PHARMACY PROGRAM

In accordance with the pertinent provisions of Republic Act (RA) No. 7722, otherwise known as the "Higher Education Act of 1994," as well as in alignment with the Philippine Pharmacy Act or Republic Act No. 10918, the latest Pharmacy Law in the country, and the Training Regulations (TR) for NC III Pharmacy Services, Republic Act (RA No. 7796), otherwise known as the TESDA Act, which pertains to the "Establishment and Administration of the National Trade Skills Standards", Republic Act No. 10647, otherwise known as the "Ladderized Education Act of 2014, " in pursuance of an outcome-based quality assurance system as advocated under CM° No. 46 s. 2012, and by virtue of Commission en Banc Resolution No. 465-2018 dated August 28,2018, and for the purpose of rationalizing pharmacy education in the country with the end goal of keeping abreast with the demands of national relevance and global responsiveness, the following Policies, Standards and Guidelines (PSGs) are hereby adopted and promulgated by the Commission.

ARTICLE I INTRODUCTION

Section 1 Rationale

Based on the Guidelines for the Implementation of CM0 No. 46 series of 2012, this PSG implements the "shift to learning competency-based standards/ outcomes-based education." It specifies the 'core competencies' expected of BS Pharmacy graduates "regardless of the type of Higher Education Institution (HEI) they graduated from." However, in recognition of the spirit of outcomes-based education and of the typology of HEls, this PSG also provides "flexibility and ample space for HEls to innovate in the curriculum in line with the assessment of how best to achieve learning outcomes in their particular contexts and their respective missions.

ARTICLE II AUTHORITY TO OPERATE

Section 2 Government Recognition

All private higher education institutions (PHEls) intending to offer BS Pharmacy must first secure proper authority from the Commission in accordance with these PSGs. All HEls with an existing BS Pharmacy program are required to shift to an outcomes-based approach as mandated by this PSG. Autonomous and deregulated institutions, state

Higher Education Development Center Building, C.P. Garicia Ave., UP Campus, Diliman, Quezon City, Philippines Web Site www ched gov oh Tel. Nos. 8441-1177, 8385-4391, 8441-1169, 8441-1149, 8441-1170, 8441-1216, 8392-5296, 8441-1220

8441-1228, 8988-0002, 8441-0750, 8441-1254, 8441-1235, 8441-1255, 8411-8910, 8441-1171, 8352-1871

universities and colleges (SUCs), and local colleges and universities (LUCs) should likewise strictly adhere to the provisions in this PSG as stipulated in CM° No.40 s. 2008 "Manual of Regulations for Private Higher Education."

ARTICLE III GENERAL PROVISIONS

Per Section 13 of RA No. 7722, the higher education institutions shall exercise academic freedom in its curricular offerings but must comply with the minimum requirements for specific academic programs, the general education distribution requirements and the specific professional courses.

Section 3

Section 4

The Articles that follow give minimum standards and other requirements and prescriptions. The minimum standards are expressed as a minimum set of desired program outcomes which are given in Article IV Section 6. The CHED designed a curriculum to attain such outcomes. This curriculum is shown in Article V Section 9 as a sample curriculum. The number of units of this curriculum is hereby prescribed as the "minimum unit requirement" under Section 13 of RA No. 7722. In designing the curriculum, the CHED employed a curriculum map described in Article V Section 10 as a sample curriculum map.

Using a learner-centered/outcomes-based approach, the CHED also determined appropriate sample curriculum delivery methods as shown in Article V Section 12. The sample course syllabi given in Article V Section 13 show some of these methods.

Based on the curriculum and the means of its delivery, the CHED determined the physical resource requirements for the library, laboratories and other facilities and the human resource requirements in terms of administration and faculty as shown in Article VI.

The HEls are allowed to design curricula suited to their own contexts and missions provided they can demonstrate that the same leads to the attainment of the required minimum set of outcomes, albeit by a different route. In the same vein, they have latitude in terms of curriculum delivery and in terms of specification and deployment of human and physical resources as long as they can show that the attainment of the program outcomes and satisfaction of program educational objectives can be assured by the alternative means they propose.

The HEls can use the CHED Implementation Handbook for Outcomes-Based Education (OBE) and the Institutional Sustainability Assessment (ISA) available in CHED website, as a guide in making their submissions in Article VIII.

Page 2 of 49

ARTICLE IV PROGRAM SPECIFICATIONS

Section 5 Program Description

5.1 Degree Name

The degree program described herein shall be called Bachelor of Science in Pharmacy (ASP).

5.2 Nature of the Field of Study

The outcome-based program is at least a four (4)-year degree program with a total of 169 credit units, equivalent to 4,515 hours. The program offers a good mix of general education courses, which have relevant applications in the profession of pharmacy, and professional courses, that will help prepare the graduates in acquiring competencies necessary in the workplace. Foundation courses in pharmaceutical chemistry, pharmaceutics and the life sciences will enhance the understanding of pharmaceutical product development and their applications in pharmacy practice. It also includes internship programs in the last year that involve assigning students to different CHED-accredited affiliation establishments covering a minimum of 1,200 hours. The intern/student, during the course of the internship or supervised pharmacy practice experience, will be exposed to a variety of opportunities in practice areas that will prepare them for the different roles expected of them upon graduation.

5.3 Program Goals

The program aims to produce graduates who can portray the following roles:

Professional pharmacist Pharmaceutical care provider Researcher Manager and entrepreneur Educator

5.4 Specific Professions/careers/occupations for graduates

Graduates of the AS Pharmacy program may pursue a career in any of the following areas of pharmacy practice:

pharmaceutical manufacturing/production, production planning and inventory control, quality assurance, research and development, regulatory affairs, academe, hospital pharmacy, clinical pharmacy, community pharmacy, cosmetics industry, veterinary industry,

Page 3 of 49

I. clinical research, government service (Department of Health, Food and Drug Administration, PhilHealth, Professional Regulation Commission, Philippine Drug Enforcement Agency, Dangerous Drugs Board, and others), health publications, sales or marketing institutional pharmacy (non-pharmaceutical establishments with pharmacy services, such as those in the Supreme Court, San Miguel Corp, GSIS, etc)

5.5 Allied Fields

All health science programs are considered to be allied fields of the BS Pharmacy program.

Section 6. Program Outcomes

The minimum standards for the BS Pharmacy program are expressed in the following minimum set of program outcomes:

6.1 Common to all programs in all types of schools:

The ability to engage in lifelong learning and understanding of the need to keep abreast of the developments in the specific field of practice. (PQF level 6 descriptor) The ability to effectively communicate orally and in writing using both English and Filipino The ability to work effectively and independently in multi-disciplinary and multi-cultural teams. (PQF level 6 descriptor) A recognition of professional, social, and ethical responsibility An appreciation of "Filipino historical and cultural heritage" (based on RA No. 7722)

6.2 Based on HEI type (CHED Implementation Handbook for OBE and ISA, 2013):

Graduates of professional institutions demonstrate a service orientation in one's profession Graduates of colleges participate in various type of employment, development activities, and public discourses, particularly in response to the needs of the communities one serves Graduates of universities participate in the generation of new knowledge or in research and development projects Graduates of State Universities and Colleges must, in addition, have the competencies to support "national, regional and local development plans" (RA No. 7722).

6.3 Common to all health-related professions

Graduates of the BS Pharmacy program shall have the following attributes common to all health-related professions:

a. Demonstrate competence in handling health problems of individuals, families, communities

Page 4 of 49

Demonstrate higher order thinking skills, problem solving, decision-making, logical and critical thinking skills Subscribe to professional, legal, and ethical practice Work collaboratively with inter- and multi-professional teams Communicate proficiently Engage in self-directed lifelong learning, and Promote the use of health system approach in the delivery of service

6.4 Specific to the BS Pharmacy Program

Program Outcomes

Operational Definition of Program Outcomes

Practice pharmacy in a professional and ethical manner

Adhere to legal requirements, practice standards and code of ethics for the pharmacy profession. Apply knowledge & skills of mathematics, health sciences, social sciences, psycho-social sciences, physical sciences, environmental sciences, natural sciences, information technology and other advanced technologies to the practice of pharmacy. Apply suitable techniques and principles in the compounding, storage, manufacturing, distribution, administration and disposal of pharmaceutical (biologicals) products to ensure quality, safety & efficacy of products.

Provide pharmaceutical care

Develop a drug therapy plan appropriate for the patient based on evaluated patient's health and medication history Provide relevant information in dispensing pharmaceutical products in accordance to practice standards. Monitor the patient's progress in achieving specific outcomes and optimize patient's health-related quality of life. Collaborate effectively with the patients and other members of the health care team in accordance to practice standards.

Conduct relevant research and disseminate findings

Conduct and participate i n research activities in accordance to scientific research guidelines and dissemination of findings for utilization.

Apply managerial and entrepreneurial skills

Demonstrate efficient and effective management skills in any organization. Demonstrate entrepreneurial skills while ensuring patient safety.

Communicate and facilitate effectively.

Facilitate learning of selected learners for specific purposes (patients, students, peers, support staff, other health professionals) Communicate effectively using culturally-appropriate language.

Section 7. Performance Indicators

This section contains a list of competency standards or performance indicators that will measure the attainment of each of the identified program outcomes. These competency standards have been determined according to the roles expected to be performed by the graduates in their workplace. These performance indicators will serve

Page 5 of 49

as bases for the assessment of student achievement/performance in various courses in the curriculum. A sample set of performance indicators is shown in Annex A.

ARTICLE V CURRICULUM

Section 8. Curriculum Description

Any pharmacy school/college/university shall adopt a curriculum that is aligned with its Institutional goals, vision and mission. The curriculum, however, must conform to the program outcomes described in Article IV. The school should have policies and guidelines to ensure that the curriculum design conform with the following requirements:

8.1 BS Pharmacy is at least a four (4)-year program, with a total of 169 credit units, equivalent to 4,515 hours, the last year of which consists of 1,200 hours of internship or supervised pharmacy practice experience that is required for the Pharmacist Licensure Examination. The guidelines for the internship program can be found in a separate set of guidelines.

8.2 The curriculum should be designed in accordance to the needs-based professional education model of the International Pharmaceutical Federation (FIP) (published in the 2012 FIP Global Pharmacy Workforce Report) with consideration of the needs of professional practice and the Filipino society, the scope of the practice of pharmacy as stipulated in Section 4, Article 1 of the Philippine Pharmacy Act (RA 10918), the Philippine Qualifications Framework (PQF), the Philippine Practice Standards for Pharmacists (PhilPSP) and other international professional competency standards.

8.3 The minimum curricular content shall include the following areas:

Pharmacy Practice (includes Dispensing I & II; Clinical Pharmacy and Pharmacotherapeutics; Pharmacy Administration, Management and Leadership; Pharmaceutical Marketing and Entrepreneurship; Legal Pharmacy and Ethics; Pharmaceutical Manufacturing & Quality Assurance; Cosmetics Product Development; Hospital Pharmacy; Health Technology Assessment, Health Policy & Pharmacoeconomics; Social & Administrative Pharmacy ; Public Health Pharmacy & Pharmacoepidemiology; Internship or Experiential Pharmacy Practice Experience in five areas: Public Health and Regulatory Pharmacy, Hospital Pharmacy, Industrial Pharmacy, Community Pharmacy, and Institutional Pharmacy)

Pharmacy Science (Drug Discovery and Development; Biological Sciences; Pharmaceutical Microbiology & Parasitology; Pharmaceutical Toxicology; Pharmacology and Pharmaceutical Chemistry)

8.4 The minimum curricular content, regardless of the curriculum design, must include the following topics that must be integrated in the

Page 6 of 49

aforecited professional pharmacy courses throughout the 4-year period of study:

TOPICS FOR INTEGRATION PROFESSIONAL PHARMACY COURSES Professionalism and Good x Practices (GxP) (Good Pharmacy Practices, Good Manufacturing Practices, Good Clinical Practices, Good Storage Practices, Good Distribution Practices, Good Compounding Practices, Good Regulatory Practices, Good Pharmacoviqilance Practices)

All professional pharmacy courses

Patient Safety (Rational use of medicines, Antimicrobial resistance and antimicrobial stewardship, Immunization Techniques and Safe Administration of Vaccines, as well as Adverse Events Following Immunization, Safety Assessment of Cosmetics) and Quality Risk Management

Introduction to the Health System; Pharmaceutical Microbiology and Parasitology; Dispensing I & II; Public Health Pharmacy & Pharmacoepidemiology; Clinical Pharmacy and Pharmacotherapeutics; Pharmacology; Pharmaceutical Manufacturing and Quality Assurance; Human Physiology & Pathophysiology; Cosmetics Product Development

Disaster Risk Reduction and Management

Introduction to the Health System; Pharmaceutical Microbiology and Parasitology; Dispensing I & II; Public Health Pharmacy & Pharmacoepidemiology; Clinical Pharmacy and Pharmacotherapeutics

Leadership and Management (including development of non- technical skills or soft skills)

Introduction to Pharmacy Administration, Management and Leadership; Pharmaceutical Administration and Management; Pharmaceutical Marketing and Entrepreneurship

Interprofessional Education (IPE) as an effective approach in collaboration

Hospital Pharmacy; Public Health Pharmacy & Pharmacoepidemiology; Pharmaceutical Manufacturing and Quality Assurance; Social & Administrative Pharmacy; Clinical Pharmacy & Pharmacotherapeutics; Internship courses

Counterfeit Medicines and SSFFC (Substandard, Spurious, Falsely labeled, Falsified and Counterfeit medical products)

Public Health Pharmacy & Pharmacoepidemiology; Dispensing I and II; Introduction to the Health System; Clinical Pharmacy & Pharmacotherapeutics; Pharmaceutical Manufacturing and Quality Assurance

Pharmaceutical Promotion & Ethics Pharmaceutical Marketing & Entrepreneurship

Philippine Practice Standards for Pharmacists (PhilPSP)

All professional pharmacy courses

Pharmaceutical Supply Chain Management

Public Health Pharmacy & Pharmacoepidemiology; Dispensing I & II; Introduction to the Health System; Clinical Pharmacy and Pharmacotherapeutics; Legal

it

Page 7 of 49

TOPICS FOR INTEGRATION PROFESSIONAL PHARMACY COURSES Hospital Pharmacy; Health Technology Assessments, Health Policy & Pharmacoeconomics; Legal Pharmacy and Ethics; Pharmaceutical Manufacturing and Quality Assurance

8.5 The curriculum should include 36 units of revised GE courses, in accordance with CHED CM0 No. 20 series of 2013, with 24 units of core courses, 9 units electives and 3 units Life & Works of Rizal (mandatory), as well as 14 units comprising 8 units of Physical Education (PE) and 6 units of NSTP, for a total of 50 units of non-professional courses.

Section 9. Sample Curriculum

For the guidance of all higher education institutions offering the BS Pharmacy program, a sample curriculum for the 4-year BS Pharmacy generic to all types of higher education institutions was designed as classified under CM° No. 46 s. 2012. Program outcomes and specific year level learning outcomes or competency standards have likewise been developed and formulated. The sample curriculum is shown in Annex B.

Each HEI shall develop its own curricular goals aligned to its vision and mission, and shall submit the syllabi for all courses based on their curriculum and means of course delivery including instructional designs.

The HEls shall also include courses under the revised General Education curriculum as stated in CM° No. 20, series of 2013.

Section 10. Sample Curriculum Map

The sample curriculum map is a matrix of all courses per semester per year level and the minimum set of program outcomes for BS Pharmacy. The curriculum map is the basic means on how to derive the courses and credit units from the required set of program outcomes. The matrix shall show the degree of breadth and depth that these courses contribute to achieving the program outcomes. Each HEI will design the curriculum based on the results of curriculum mapping, and determine which of the courses will be enhanced, revised or deleted, to be aligned with the program outcomes. A sample curriculum map (Annex C) is included wherein courses are categorized according to how program outcomes are covered in the course:

I Introduced Program outcomes are merely introduced in the course

P Practiced Program outcomes are not just introduced but practiced in the course, with supervision

D Demonstrated Program outcomes are practiced, demonstrated and assessed in the course, with little or no supervision

Page 8 of 49 e

Section 11. The Philippine Qualifications Framework (Level 6)

Domains Descriptors

Knowledge, Skills and Values

Graduates at this level have broad and coherent knowledge and skills in their field of study for professional work and lifelong learning

Application Application in professional work or research in a specialized field of discipline and/or for further study

Degree of Dependence Independent and /or in teams of related field with minimal supervision guided by set procedures that frequently require judgment.

Qualification Type Baccalaureate Degree

Section 12. Sample Means of Curriculum Delivery

The pharmacy school shall prepare a clear means of curriculum delivery of program outcomes and their competency standards or performance indicators as shown in Annex D.

Section 13. Sample Syllabi for Selected Course

The pharmacy school shall prepare instructional designs and syllabi for all professional courses, a sample of which can be found in Annex E.

Each syllabus shall contain the following: Course title/number Course description Credit units with equivalent number of hours Description of Students and their year level Instructional SettingsNenue Program/Learning outcomes, competency standards, course objectives and learning objectives Teaching learning activities and instructional resources Suggested references Other Resources required Assessment and evaluation

ARTICLE VI REQUIRED RESOURCES

Section 14. Program Administration

14.1 The Dean

a. The school/college/department of pharmacy shall be administered by a duly appointed Dean/Program Head with the following minimum qualifications:

Must be a duly licensed pharmacist with at least a Master of Science degree in Pharmacy.

Page 9 of 49

Must have 5 years of teaching experience, and with at least two (2) years of administrative or supervisory experience.

The general function and responsibility of the Dean is to effectively and efficiently manage the pharmacy education program and the operations of the College or School of Pharmacy.

The Dean must be employed in the school of pharmacy on a full-time basis (at least 40 hours per week). The Dean shall not have any other appointment/s as faculty member or Dean in any other University or school of pharmacy, for both undergraduate and graduate programs.

14.2 The Faculty

a. Qualifications

The faculty for the professional pharmacy courses must have the following qualifications:

A duly licensed pharmacist Has at least a Master's degree in Pharmacy (Clinical Pharmacy,

Social & Administrative Pharmacy, Pharmaceutical Sciences, Pharmaceutical Regulatory Science, Public Health Pharmacy, Pharmaceutical Supply Chain Management, Health Technologies Assessment & Pharmacoeconomics, and other related pharmacy courses)

Teaching Assignment/Load

The faculty must have a teaching assignment/load in accordance with his/her academic preparation.

The teaching load must be in accordance with the provisions stated in the Manual of Regulation for Private Schools/State Universities and Colleges.

Employment Status

Full-time (at least 30 working hours a week or as determined by the University); shall not teach in another school, except in meritorious cases where his/her expertise is needed, provided permission is granted by the pharmacy school where he/she is employed as full-time. Part-time (less than 30 working hours a week or as determined by the University) For initial permit, at least four (4) faculty members must be working on a full-time basis to handle an initial class of 50 students For recognition of the program, at least sixty percent (60%) of the total number of faculty handling professional subjects must be working full time, which includes teaching, administrative and research load.

Page 10 of 49

Section 15. Library

Library personnel, facilities and holdings should conform to existing CHED requirements for libraries which are embodied in a separate issuance.

Section 16. Laboratory and Physical Facilities

Classroom requirements

The school/college/department of pharmacy must provide lecture and laboratory rooms, facilities, materials and equipment that are adequate for instruction, laboratory work and research.

Laboratory requirements

The school/college/department of pharmacy should have a laboratory coordinator / manager, who is a graduate of pharmacy, to oversee the operations of pharmacy laboratories.

i. A laboratory room should have: A well-lighted, well-ventilated, clean and well-maintained facility, and provided with accessible functional safety devices and first aid kits; An adequate working area for the convenience of students and faculty; laboratory table/countertops that are chemical and fire-resistant; adequate lockers for students when needed; and two (2) doors serving as entrance and exit.

Separate laboratory rooms for the animal, microbiology and pharmaceutical sciences and research should be provided.

Facilities in the pharmaceutical sciences laboratory should include:

An adequate supply of deionized/demineralized/ purified/distilled water; electricity properly identified as to voltage; water; and gas. Safety, emergency and first aid devices, such as, fire extinguisher, first aid cabinet, emergency shower, eye wash station, exhaust system and fume hoods should be available, accessible and properly maintained. There must be separate storage rooms for chemicals and equipment under the supervision of a trained laboratory technician.

iv. Provision should be made for maintaining live plants, animals and microorganisms for study

Special equipment should be provided for the teaching of professional pharmacy courses involving biological materials (Refer to Annex F). Adequate space should be provided in the school campus for a medicinal plant garden.

Page 11 o149

There should be a separate well- maintained and properly ventilated laboratory animal room, preferably compliant with guidelines of Institutional Animal Care and Use Committee (IACUC). Instrument room should be provided for analytical tests and should be air-conditioned. Microbiological lab should be separate from the other rooms and equipped with laminar flow hood that is regularly maintained and calibrated

v. Laboratory equipment and supplies should: Be adequate for each laboratory course based on the year level and number of students Be functional, properly maintained and periodically calibrated Include other teaching aids as needed for efficient instruction in the laboratory Refer to Annex F for the list of laboratory equipment, facilities and supplies

vi. Laboratory Standard Operating Procedures (SOPs) should be documented, implemented and monitored regularly by the Laboratory Manager/Coordinator.

c. Audio-visual equipment

There should be separate multimedia facilities consisting of USB-enabled TV, LCD, computers with internet access and other relevant equipment to enhance instruction of professional pharmacy courses.

ARTICLE VII INTERNSHIP

Section 17 General Guidelines

The areas of experiential pharmacy practice or internship include: community pharmacy, hospital pharmacy, industry, institutional, as well as public health and regulatory pharmacy; The internship program should be CHED-accredited that is based on learning outcomes for the interns in the respective area of internship. There should be trained preceptors available in the internship site who are willing and capable of providing the appropriate learning experience to the interns. Each area of internship has a minimum number of hours as stipulated in the internship guidelines subject to updating by the CHED in consultation with the organization of schools of pharmacy. Template for the Memorandum of Agreement between the school and the internship facility will be provided by CHED. An affiliation fee will be paid by the school to the internship facility. It is imperative for the internship facility to pay the preceptor's fee (part of the affiliation fee) on top of the regular salary. Basis for this fee is stipulated in the Annex of the MOA for internship.

Page 12 of 49 tin'

The individual insurance, which is included in the MOA, should be facilitated by the school, if the student is not yet insured. The internship may be scheduled any day of the week including holidays during business hours for as long as the supervising licensed pharmacist permits it. The intern should have one day off a week.

I. CHED will accredit the internship facilities and will make available a list of the accredited facilities to the HEls. Internship in foreign countries shall be allowed provided rules and regulations of CHED international off-campus activities shall be strictly followed. Student evaluation of the internship program is based on an assessment or evaluation tool, a sample of which will be prepared by CHED. The preceptors and faculty coordinators will evaluate the performance of interns based on assessment criteria.

I. The preceptor must be a licensed pharmacist in the training site who has undergone preceptorship training in accordance to CHED training standards and regulations, and must have worked as a pharmacist for at least 1 (one) year.

m. The faculty coordinator must be a licensed pharmacist from the HEI who has observed the facility operations for at least one (1) week and must have worked as a pharmacist for at least 2 (two) years.

ARTICLE VIII COMPLIANCE OF HEls

Using the CHED Implementation Handbook for OBE and ISA as reference, a HEI shall develop the following items which will be submitted to CHED when they apply for a permit for a new program:

Section 20. The complete set of program outcomes, including its proposed additional program outcomes.

Section 21. Its proposed curriculum and its justification including a curriculum map.

Section 22. Proposed performance indicators for each outcome. Proposed measurement system for the level of attainment of each indicator.

Section 23. Proposed outcomes-based syllabus for each course.

Section 24. Proposed system of outcomes-based program assessment and evaluation

Section 25. Proposed system of program Continuous Quality Improvement (COI).

For existing programs, CHED shall conduct regular monitoring and evaluation on the compliance of HEls on this Policies, Standards and Guidelines using an outcomes-based assessment instrument.

Page 13 of 49

ARTICLE IX HEI PERFORMANCE MONITORING AND EVALUATION

Section 26. Performance of HEls in the Pharmacist Licensure Examination and compliance with the existing policies, standards and guidelines (PSG) for BS Pharmacy program shall be jointly monitored by CHED and PRC, regardless of the status of the school. Pharmacy schools whose performance in the Pharmacist Licensure Examination is below the national passing average shall undergo consultancy visit by the accredited Philippine Association of Colleges of Pharmacy (PACOP) for technical assistance.

Section 27. Pharmacy schools are encouraged to undergo external accreditation for quality assurance.

Section 28. Sanctions

28.1 Non-compliance with the provisions of this CMO, after due process, shall cause the Commission to impose sanctions. The sanctions for pharmacy schools shall be based on the results of the 3-year consolidated Pharmacist Licensure Examinations, institutional performance and the outcome of the monitoring visits and HEls shall adhere to the following guidelines:

28.2 Compliance of pharmacy schools shall be based on the following:

Performance of their graduates in the Pharmacist Licensure Examinations

The total institutional passing average or performance of the graduates for the past three (3) years based on data provided by the Professional Regulatory Board of Pharmacy.

Outcome/results of the Joint CHED-PRC monitoring and evaluation activities on these areas:

Dean/Administration Faculty Curriculum and Instruction (including mandatory topics in the syllabi

for course integration) Laboratory and Physical Facilities Library Resources and other Learning Facilities Research Internship (CHED-accredited internship sites, preceptor & faculty

internship coordinator, evaluation of internship program)

28.3 Overall Performance in the Pharmacist Licensure Examination

Effective Academic Year 2021-2022 and yearly thereafter, HEls offering BSP program whose average passing percentage in the Pharmacists Licensure Examination is fifty percent (50%) and below for the immediate past three (3) consecutive years shall be imposed sanctions based on the following:

Page 14 of 49 (0.)

"ftse

Overall Exam Performance

(Passing Average) Action/s

30-50% Warning CHED monitoring visit in one (1) year

20-29% Probation CHED monitoring visit in 6 months

Below 20% Phase out program Stop admissions with gradual phase out

The HEls passing average in the Board Exam for programs to be phased out shall consider ratings of examinees who took the exam.

28.4 Monitoring and Evaluation visits

Effective Academic Year 2021-2022 and yearly thereafter, HEls offering BSP program that are subjected to Joint CHED-PRC monitoring and evaluation shall be imposed sanctions for non-compliance with these PSGs based on the following:

Non-Compliance with Areas of Evaluation in PSG Action/s

1 area Warning

Yearly visit for 2 years Phase-out if non-compliant on the second visit

2 areas

Probation Revisit in 6 months Phase out if non-compliant on the second visit

More than 2 areas Phase out program Stop admissions with gradual phase out

ARTICLE X TRANSITORY, REPEALING and EFFECTIVITY PROVISIONS

Section 29. Transitory Provision

All private HEls, state universities and colleges (SUCs) and local universities and colleges (LUCs) with existing authorization to operate Bachelor of Science in Pharmacy (BSP) program are hereby given a period of three (3) years from the effectivity thereof to fully comply with all the requirements in this CMO. However, the prescribed minimum curricular requirements in this CM0 shall be implemented starting Academic Year 2021-2022.

Page 15 of 49

Section 30. Repealing Clause

Any provision of this Order, which may thereafter be held invalid, shall not affect the remaining provisions.

All CHED issuances, rules and regulations or parts thereof that are inconsistent with the provisions of this CM0 are hereby repealed.

Section 31. Effectivity Clause

Higher education institutions (HEls) that opted to implement this CM0 shall allow their existing students to finish BSP curriculum under CMO No. 3 series of 2006.

This set of Policies, Standards and Guidelines shall take effect beginning Academic Year 2021-2022, fifteen (15) days after its publication in the Official Gazette or in a newspaper of national circulation.

Quezon City, Philippines, goy ember 9 , 2021

For the Commission:

J. PROS ERO E. DE VERA III, DPA Chairman

Attachments:

ANNEX A: Sample Performance Indicators ANNEX B: Sample Curriculum of the 4-Year BS Pharmacy Program ANNEX C: Sample Curriculum Map ANNEX D: Sample Curriculum Delivery Methods ANNEX E: Sample Course Syllabi & Instructional Design ANNEX F: List of Laboratory Equipment/Facilities/Supplies

Page 16 of 49

ANNEX A Sample Performance Indicators

ROLE: Researcher PROGRAM OUTCOME: Conduct relevant research and disseminate findings. COMPETENCY STANDARDS / PERFORMANCE INDICATORS:

Critically appraise research evidence. Prepare proposal according to guidelines of scientific research. Conduct and participate in research according to technical and ethical standards. Write and disseminate research findings for publication and utilization.

Page 17 of 49

ANNEX B Sample Curriculum of the 4-Year BS Pharmacy Program

FIRST YEAR First Semester

COURSE TITLE CREDIT UNITS PRE-

REQUISITE CO- REQUISITE LEC LAB TOTAL

Pharmaceutical Botany with Taxonomy

1 1 2

Pharmaceutical Inorganic Chemistry (with Qualitative

2 1 3

Analysis)

Perspectives in Pharmacy 2 2

Pharmaceutical Calculations & Techniques

2 1 3

GE Elective 1 3 3

GE Core 1 3 3 GE Core 2 3 3

PE I 2 2

NSTP 1 3 3

TOTAL 21 3 24

Second Semester


REQUISIT E

CO- REQUISITE LEC LAB TOTA

L Pharmaceutical Organic Chemistry

2 1 3

Introduction to the Health System

1 1

Introduction to Pharmacy Administration, Management and Leadership

2 2

Human Physiology and Pathophysiology

3 1 4

Pharmaceutical Analysis 1 (Quantitative Pharmaceutical Chemistry)

2 1 3

GE Elective 2 3 3

GE Core 3 3 3

PE 2 2 2

NSTP 2 3 3 TOTAL 21 3 24

Page 18 of 49

FIRST YEAR LEARNING OUTCOMES:

1. Demonstrate appreciation of pharmacy as a health profession and the scope of practice.

2 Demonstrate understanding of chemical, physical, and biological processes relevant to pharmaceutical sciences.

3. Recognize the importance of the healthcare system and its components, including the importance of pharmacovigilance.

4 Perform pharmaceutical calculations and appropriate laboratory techniques. 5 Demonstrate understanding of morphology, anatomy, physiology, taxonomy, and

distinct features of plant species of pharmaceutical importance. Relates ethical practices to administration, management and leadership in pharmacy. Identify the different elements or components in a pharmacy operation while practicing good management skills. Demonstrate understanding of the relationship among different levels of body functions from molecular to systemic level in normal conditions and diseased states, including the impact of immunization in vaccine-preventable diseases. Demonstrate proper adult vaccine administration techniques. Practice good housekeeping in the laboratory and other working areas. Manifest a sound understanding of oneself in relation to others and the society. Communicate effectively to appropriate audience. Demonstrate an appreciation of mathematics and its relevance to science.

Page 19 of 49

SECOND YEAR First Semester



Pharmaceutical Dosage Forms, Drug Delivery Systems and Medical Devices

2 2 4 Pharmaceutical Calculations & Techniques

Dispensing I (Dispensing Process, Reading & Interpreting the Prescription and Other Medicine Orders)

1 1 2 Pharmaceutical Calculations & Techniques

Pharmaceutical Biochemistry

2 1 3 Pharmaceutical Organic Chemistry

Physical Pharmacy 2 1 3 Pharmaceutical Dosage Forms, Delivery Systems and Medical Devices

Pharmaceutical Microbiology and Parasitology

2 2 4

GE Core 4 3 3

GE Mandated: Life and Works of Rizal

3 3

PE 3 2 2 TOTAL 17 7 24

SECOND YEAR Second Semester

COURSE TITLE

CREDIT UNITS

PRE- REQUISITE

CO-REQUISITE LEC LAB

_i 4 p- 0

Pharmaceutical and and Medicinal Organic Chemistry

2 1 3 Pharmaceutical Organic Chemistry

Pharmacognosy and Plant Chemistry

Pharmacognosy and Plant Chemistry

2 1 3 Pharmaceutical Botany

Page 20 of 49

Pharmaceutical Analysis 2 (Instrumental Methods of Analysis)

2 1 3 Pharmaceutical Analysis 1

Physical Pharmacy

Pharmacology 1 3 3 Human Physiology and Pathophysiology

Pharmaceutical Microbiology and Parasitology

Pharmacy Informatics

1 1 2 Second Year Standing

GE Core 5 3 3

GE Elective 3 3 3

GE Core 6 3 3

PE 4 2 2 TOTAL 21 4 25

SECOND YEAR LEARNING OUTCOMES:

Explain the preparation of drugs into various dosage forms to ensure quality of medicinal and pharmaceutical products.

Demonstrate knowledge of drugs of biological origin, and the pharmacy and chemistry of pharmaceutical products.

Read and interpret prescriptions correctly. Critically evaluate scientific evidence for research and decision-making. Relate biological and physiological concepts to pharmacy (drugs, biotechnology

products, and diseases). Investigate the harmful and beneficial effects of microorganisms (including

antimicrobial resistance and its clinical impact) as well as the helminths and measures to control these parasites.

Demonstrate understanding of immunization process and types of immunobiologicals.

Demonstrate methods in utilizing instrumentation analyses as required by pharmacopeial standards.

Provide healthcare information to various clients (patients, healthcare professionals and public).

Recognize important elements of the patient's health profile and health promotion Demonstrate appreciation of the major art forms. Demonstrate an appreciation of history and cultural heritage.

Page 21 of 49

THIRD YEAR First Semester



Biopharmaceutics & Pharmacokinetics

3 3 Physical Pharmacy

Pharmaceutical Manufacturing (with Regulatory Pharmacy, Quality Assurance and cGMP)

2 2 4 Physical Pharmacy

Dispensing II (Medication related problems, Medication safety, Medication counseling and other Pharmacy services)

2 1 3 Pharmaceutical Dosage Forms, Drug Delivery Systems and Medical Devices

Dispensing I

Drug Discovery, Design & Development

1 1 3rd year standing

Pharmacology 2 3 3 Pharmacology 1

Clinical Pharmacy and Pharmacotherapeutics 1

3 3 Pharmacology 1

Pharmacology 2

Pharmacy Research Methods with . Pharmaceutical Statistics

1 1 2 Pharmacy Informatics

Hospital Pharmacy 2 2 3m year standing

Dispensing II

GE Core 7 3 3

TOTAL 20 4 24

THIRD YEAR Second Semester

COURSE TITLE

CREDIT UNITS PRE-REQUISITE CO-

REQUISITE

am tLIJ 1 TO

TAL

Pharmaceutical Toxicology _

2 1 3 Pharmacology 2

(ono%

Page 22 of 49

Clinical Pharmacy and Pharmacotherapeutics 2

3 3 Clinical Pharmacy and Pharmacotherapeutic 51

Public Health Pharmacy (with Pharmacoepidemiology)

3 3 Pharmaceutical Microbiology and Parasitology

Cosmetic Product Development (Cosmetic product development, regulation and safety assessment)

1 1 2 Pharmaceutical Manufacturing & QA

Pharmacy Research and Thesis Writing

1 2 3 Pharmacy Research Methods with Pharmaceutical Statistics

Health Technology Assessment (with Pharmacoeconomics)

2 2 3m year standing

Social and Administrative Pharmacy

1 1 3m Year Standing

Pharmaceutical Marketing and Entrepreneurship

2 2

Legal Pharmacy and Ethics

2 2 3rd year standing

GE Core 8 3 3 TOTAL 20 4 24

THIRD YEAR LEARNING OUTCOMES:

Explain the drug development process (how medicines including biotech products are developed, manufactured and brought to the market).

Formulate, compound and manufacture pharmaceutical and cosmetic products according to official standards, PhilPSP and regulatory guidelines (national and ASEAN).

Demonstrate analytical and problem-solving skills in dispensing medicines. Relate biological and physiological concepts to pharmacy (drugs, biotechnology

products and diseases). Apply management and accounting principles. Demonstrate marketing and entrepreneurial skills in pharmacy practice. Demonstrate skills in providing pharmacy services, such as but not limited to, adult

vaccine administration, including monitoring for Adverse Events Following Immunization (AEFI).

Demonstrate proper medication counseling skills. Participate as a healthcare team member and demonstrates effective

interprofessional skills. Integrate formulation with drug delivery, clinical effectiveness, and safety through

evidence-based outputs. Formulate evidence-based pharmaceutical care plans. Identify and provide interventions in drug related problems.

Page 23 of 49

Apply public health principles and tools including pharmacoepidemiologic methods, strategies and interventions in medication and relevant health care issues and policies that impact patient safety, as well as pharmacovigilance.

Perform technically and ethically sound research relevant to pharmacy. Employ appropriate techniques in the medication use process. Apply standards and evidence-based practices related to safe and effective

medication use. Demonstrate understanding of the pharmacy law, administrative orders, other

regulatory issues affecting the practice of pharmacy including ethical principles in professional and social contexts.

Apply assessment techniques and health technologies including pharmacoeconomic evaluation.

Integrate principles of social and administrative pharmacy in relevant pharmacy applications.

FOURTH YEAR (Prerequisite: Must pass ALL courses from 1st to 3 year)

First Semester

COURSE TITLE TITLE CREDIT UNITS PREREQUISITE

REQUISITE UNIT HOURS

Experiential Pharmacy Practice in Institutional Pharmacy*

2.4 120 hrs 4th year standing

Experiential Pharmacy Practice in Public Health and Regulatory Pharmacy

3.6 180 hrs 4th year standing

Experiential Pharmacy Practice in Community Pharmacy

6 300 hrs 4th year standing

TOTAL 12 600 hrs *Student may opt to enroll in Community Pharmacy for the 120 hours in addition to the required 300 hours for Community Pharmacy, for a total of 420 hours.

Second Semester


REQUISITE CO- REQUISITE

UNIT HOURS

Experiential Pharmacy Practice in Hospital Pharmacy


Experiential Pharmacy Practice In Industrial Pharmacy


Page 24 of 49

TOTAL 12 600 hrs

FOURTH YEAR LEARNING OUTCOMES:

In general, the student is expected to be able to practice pharmacy in actual CHED-accredited pharmacy establishments supervised by preceptors in hospital, industry, community, institutional, public health units and health regulatory agencies.

Learning outcomes specific for each internship program are listed in the separate guidelines on internship.

Page 25 of 49

SUMMARY OF GENERAL EDUCATION (G.E.) COURSES + MANDATED COURSES

Total Number of Units (GE + Mandated): 50 UNITS

G.E. Subjects No. of Units GE 1 3 GE 2 3 GE 3 3 GE 4 3 GE 5 3 GE 6 3 GE 7 3 GE 8 3

G.E. Electives: GE Elective 1 Social Sciences & Philosophy Math, Science & Technology

Mandated (Rizal, PE, NSTP)

3 3

Life & Works of Rizal

3 Physical Education a

NSTP

6 TOTAL NUMBER OF UNITS FOR G.E. COURSES: 50

TOTAL NUMBER OF UNITS FOR PROFESSIONAL

119 COURSES:

SUMMARY OF CREDIT UNITS IN THE BS PHARMACY PROGRAM: Total Number of Units: 169 units

YEAR LEVEL 1st SEMESTER rd SEMESTER TOTAL LEC LAB TOTAL LEC LAB

First 24 21 3 24 21 3 Second 24 17 7 25 21 4 Third 24 20 4 24 20 4 Fourth (Internship) 12 12

TOTAL 84 58 14 85 62 11

BREAKDOWN SUMMARY

UNITS HOURS Lecture courses (1 unit = 17 hrs) 120 2,040 Laboratory courses (1 unit = 51 hrs) 25 1,275

Internship courses (1 unit = 50 hrs) 24 1,200

Total Number of Units (4-yr BSP) 169 4,515

Page 26 of 49

Sa

mple

Cu

rric

ulu

m M

ap

co o. 4 0 •

d1SN 9:

uoneonp3 leolsA4d —

Q. a — 0. ... — — _

Apeuueyd 0; uo4etueucj pug Ai030!H) I. UMW

, a. — — P. 0. — ... ...

vuscimactima oima6Joui

ig paues) I. A.4sp.uego

— a a 0. a. a a. — —

(Atuouoxei am Aumog

loopeoetweild) I. 'PS '019 '4d

— % Q. 0. O. 0. 0. ——

(wQ0131V 0601100) l 410lAl —

4. — — O. 0. —

se100103600Pled 6u 6u1u!5) 1 ILA — a a — 0. 0- —

(1 01IPIS uoneaNnuau03)

I. tisHOug — 0. O. — 0. — ... —

PR

OG

RA

M O

UT

CO

ME

S

Ab

ility

to e

nga

ge in life

long le

arn

ing a

nd

un

ders

tand

ing

of th

e n

eed

to

keep a

bre

ast

of th

e

de

velo

pment

s in

th

e s

peci

fic field

of

pra

ctic

e

A

bili

ty to d

em

onst

rate

eff

ect

ive c

om

mun

icat

ion a

nd

faci

litat

ion s

kills

ora

lly a

nd in

writin

g u

sing b

oth

E

ngl

ish

and

Fili

pino

Ab

ility

to w

ork

effect

ivel

y a

nd in

depe

ndent

ly in

multi

-di

scip

linar

y an

d m

ulti-

cultu

ral t

eam

s

A r

eco

gniti

on o

f pro

fessi

on

al, s

oci

al, a

nd

eth

ical

resp

on

sibili

ty

An a

ppre

ciat

ion

of "F

ilipi

no

his

torica

l and

cul

tura

l he

rita

ge" (b

ased

on

RA

7722

)

F Abili

ty to p

ract

ice p

ha

rma

cy in

a p

rofe

ssio

nal

and

et

hica

l man

ner

Abi

lity

to p

rovi

de p

ha

rma

ceut

ical

care

Abili

ty to c

ond

uct

rele

vant

re

sear

ch a

nd d

isse

min

ate

fin

din

gs

Ab

ility

to a

pply

ma

na

gem

ent

& e

ntre

pre

ne

uria

l sk

ills

vi a. a 0

diSN m 4 a a a Oaaa.

Z uoaeonpa leopAtid

m — a, 11, CL ° a. a a. a.

waisAs 9190 41199H 941 a.

— ct, so iciaouoo uao) L. am° U.1.12qd

.onpa asnqv Baia Lam ABolotioAsd a. 13. O. 0. Ct. a. — CL a

itieueo

so's/Cud imuao a. a. a. CL O. — O. O.

sogsgels oiseg O. a. 4. 0. a. a. a. a.

(119)11111-19d) Z 11d cl• a. CI. O. IL 0. O. CL 0.

(ii SI I PIS uoaeopritutuo0)3

usipu3 0- a O. CL O. a. a.

PR

OG

RA

M O

UTC

OM

ES

Abi

lity

to e

ngag

e in

life

long

lear

ning

and

und

erst

andi

ng

of th

e ne

ed to

kee

p ab

reas

t of t

he d

evel

opm

ents

in the

sp

ecifi

c fie

ld o

f pra

ctic

e A

bilit

y to

dem

onst

rate

effe

ctiv

e co

mm

unic

atio

n an

d fa

cilit

atio

n sk

ills

oral

ly a

nd in

writ

ing

usin

g bo

th Eng

lish

and

Filip

ino

A

bilit

y to

wor

k ef

fect

ivel

y an

d in

depe

nden

tly in

mul

ti-di

scip

linar

y an

d m

ulti-

cultu

ral t

eam

s A

reco

gniti

on o

f pro

fess

iona

l, so

cial

, and

eth

ical

resp

onsi

bilit

y

An

appr

eciatio

n of "F

ilipi

no h

isto

rical

and

cul

tura

l he

ritag

e" (b

ased

on

RA

772

2)

Abi

lity

to p

ract

ice

phar

mac

y in

a p

rofe

ssio

nal a

nd

ethi

cal m

anne

r

Abil it

y to

pro

vide

pha

rmac

eutic

al c

are

Abi

lity

to c

ondu

ct re

leva

nt re

sear

ch a

nd di

ssem

inat

e fin

ding

s

Abi

lity

to a

pply

man

agem

ent &

ent

repr

eneu

rial s

kills

Co O. 4 0

E uogeonp3 CL a.lethsA411 a_ a. E 0 a. 0 0. 0 0. 0.

A00,004001 uoulatwom

04 01)111

a 94 a. 0. 0. O. a.

ad 0.

kilsiweLIO °memo

(I. —

a. a. a. 1 a. a. a. a.

(iateaH viand) Z ale0 ulleLld

0. ""

0 O. a. a- a- a. 1 a. a.

ABons -Agdotiled

gym ABopisAyd v Awoleuv

ueumm

a. a.

901413 11118GH le a.

uen p AgdosolRld

0. —

a.

PR

OG

RA

M O

UT

CO

ME

S

Abi

lity

to e

nga

ge in

li fe

long

lear

ning

and

und

erst

andi

ng o

f th

e n

eed

to k

eep

abr

east

of t

he d

evel

opm

ents

in th

e

spec

ific

field

of p

ract

ice

Abi

lity

to d

emon

stra

te e

ffect

ive

com

mun

icat

ion

and

fa

cilit

atio

n s

kills

ora

lly a

nd in

wri

ting

usin

g bo

th Eng

l ish

and

Fili

pin

o

Abi

lity

to w

ork

effe c

tivel

y an

d in

depe

nden

tly in

mul

ti-di

scip

linar

y and

mul

ti-cu

ltura

l tea

ms

A r

ecog

nitio

n of

pro

fess

iona

l, so

cial

, and

eth

ical

resp

onsi

bilit

y

An

appr

ecia

tion

of "F

ilip i

no h

isto

rical

and

cul

tura

l her

itage

" ( b

ased

on

RA

7722

) I A

bili

ty to

pra

ctic

e ph

arm

acy

in a

pro

fess

iona

l and

eth

ical

man

ner

Abi

lity

to p

rovi

de p

harm

aceu

tical

car

e

Abi

lity

to c

ond

uct r

elev

ant r

esea

rch

and

diss

emin

ate

fin

ding

s

Abi

lity

to a

pply

ma

nage

men

t & e

ntre

pren

euria

l ski

lls

2 44 0

fr uoponp3 leo!sAild

0 IL

0 0 0 09 0 a. o a.

a d

ad

sogewiqui

. .... . .

hewiratid 0

E 2 2

Od

va? uoRexes Lipm so!wouoo3

LIlleaH a. 0 a_ 0 o 9: R R.

vogeinoleo leollneomweLld

o 9:

a a.

ad

'

0 0- es:22

fuisiwapole leOlineoewistid

0.

— IL R. 2 2 ° 13a .... a• — 0 I). ° Q.

SWG1S AS fuengea Bruu

0 0. 5! 2 R. 2.2ER

(anneJen auiddifiqd) 9 Liseua

R o R 0 0.

0 a.

l a

d

0 a. 0 0 a.

PR

OG

RA

M O

UT

CO

ME

S

Abi

lity

to e

ngag

e in

Mel

on°

lear

ning

and

und

erst

andi

ng o

f th

e ne

ed to

kee

p ab

reas

t of t

he d

evel

opm

ents

in the

sp

ecifi

c fie

ld o

f pra

ctic

e

Abi

lity

to d

emon

stra

te e

ffect

ive

com

mun

icat

ion

and

fa

cilit

atio

n sk

ills

oral

ly a

nd in

writ

ing

usin

g bo

th E

nglis

h

and

Fili

pino

Abi

lity

to w

ork

effe

ctiv

ely

and

inde

pend

ently

in m

ulti-

disc

iplin

ary

and

mul

ti-cu

ltura

l tea

ms

A r

ecog

nitio

n o

f pro

fess

iona

l, so

cial

, and

eth

ical

resp

onsi

bilit

y

An

appr

ecia

tion

of "F

ilipi

no h

isto

rical

and

cul

tural h

erita

ge"

(bas

ed o

n R

A 7

722)

Abi

lity

to p

ract

ice

phar

mac

y in

a p

rofe

ssio

nal a

nd e

thic

al

man

ner

Abi

lity

to p

rovi

de p

harm

aceu

tical

car

e

Abi

lity

to c

ondu

ct r

elev

ant r

esea

rch

and

diss

emin

ate

fin

ding

s A

bilit

y to

app

ly m

anag

emen

t & e

ntre

pren

euria

l ski

lls

Pag

e 3

0 o

f 4

9

Pag

e 3

1 o

f 4

9

Co a- < 0

Alliolopstied pue A6oloicionllni

lea0neoeuueed R. 0

0. 0 a.

ad

!

ad

ad

Od 0 0 O.

ftesituau0 Weld g Asou6opeupald

0 13-

0 O .

0 0R R. E 0 E

soesuppoeuueild '9

sollneoeuueud019

a 0_ a a.

ad R

ad

PD

O. 00

ad

Apeunetid leolsAild

a 0-

0 0.

0 0.

0 0.

0 4.

0 0.

0 0.

0 0-

0 0.

I siewolpeil he fumweqo 19 Apeueetid

a R e. e R.

ad

R. R

ad

Bueum leolutioei R _ ° a. E 0 a. ° a.

ad

a. 0 a.

ad

PR

OG

RA

M O

UT

CO

ME

S

•

Abili

ty to e

ng

age

in

life

long learn

ing a

nd u

nders

tand

ing of

the

nee

d t

o k

eep a

bre

ast

of th

e d

eve

lopm

ents

in the

speci

fic fie

ld o

f pra

ctic

e

Abili

ty to d

em

onst

rate

effect

ive c

om

mun

icat

ion a

nd

faci

litat

ion

ski

lls o

rally

and

in w

ritin

g u

sin

g b

oth En

glis

h

and

Fili

p in

o

Abili

ty to w

ork

eff

ect

ivel

y and

ind

epe

nde

ntly

in m

ulti

-dis

cip

linar

y a

nd m

ulti-

cultu

ral t

eam

s

A r

eco

gni

tion o

f pro

fess

ional, s

oci

al,

and

eth

ical

resp

on

sib

ility

An

appre

ciat

ion of "F

ilip i

no

his

torica

l and

cul

tural h

erit

age"

( b

ase

d o

n R

A 77

22

)

Abili

ty to p

ract

ice

ph

arm

acy

in a

pro

fess

ional a

nd e

thic

al

man

ner

Abi

lity

to p

rovi

de p

harm

ace

utic

al c

are

A

bil i

ty to c

onduct

rel

eva

nt r

ese

arc

h a

nd dis

sem

inat

e

find

ings

Abili

ty to a

pply

ma

na

ge

ment &

ent

repre

neur

ial sk

ills

CA O. < 0

slPis ieuosiediejui ig uoaeolunwwoo

0 O.

0 0.

ad

0 II.

ad

0 a.

0 a.

0 0.

0 a.

eAessv pue &meal

6rua — I, Piwoo AillenD

0 a.

0 a.

ad

E R. E PD

ad

0 a.

Aoeuueqd lelidsoH

0 a

0 a

0 a

ad

R

ad

0 11.

ad

0 a

I AbolooewiNd 0 a.

0 CI.

0 a.

0 12.

0 Ct.

0 13. 0 O. 0 O.

o a

Aoeuue4d 6uunpainueys

0 O.

00 0. Ct.

0 0. P

D

PD

0 13.

ad

ad

II sleuinGIN ;o fulsiwayo v A., R

0 a.

0 a.

0 a.

ad

R 0 a.

0 a.

0 a

PR

OG

RA

M O

UT

CO

ME

S

Ab

ility

to e

nga

ge in

li fe

lon

g le

arn

ing a

nd u

nder

stand

ing

of

the

ne

ed

to

ke

ep

abre

ast

of th

e d

eve

lopm

ent

s in

the

speci

fic fie

ld o

f p

ract

ice

Abili

ty to d

em

onst

rate

effect

ive

com

mun

icat

ion

and

fa

cili

tatio

n s

kills

ora

lly a

nd

in w

ritin

g u

sin

g b

oth

Engl

ish

and

Filip

ino

A

bili

ty to w

ork

effect

ivel

y a

nd

ind

epe

nde

ntly

in m

ulti

-dis

cip

linary

and

multi

-cu

ltura

l te

ams

A r

eco

gniti

on o

f pro

fess

ional

, so

cial

, and

eth

ical

resp

onsi

bi li

ty

An a

ppre

ciat

ion

of "F

ilip i

no

his

tori

cal a

nd c

ultu

ral h

erit

age

" ( b

ase

d o

n R

A 77

22

) A

bili

ty to p

ract

ice p

harm

acy

in a

pro

fess

ional

and

eth

ical

man

ner

Abili

ty to p

rovi

de p

ha

rma

ceut

ical

ca

re

Abil i

ty to c

onduct

rele

vant

rese

arc

h a

nd d

isse

min

ate

fin

d ing

s

Abili

ty to a

pply

managem

ent &

ent

rep

ren

eur

ial sk

ills

R IC CD

wawa6eueN 19 uoileasiquIPV

Aomweild Jo seld!pulid

13- 00 E

ad

a.

ad

R le

Od

a a.

Butiesunoo uogeopeiry

1g Buisuedsia 0 EL

0 a .

0 a.

ad

'2 E

ad

0 a.

0 a.

eugum sisaiu womesed Aoeuueqd

Ely. 0 a. 0 O.

0 0.

0 0.

0 O.

0 O.

ad

ad

uoaeluawruisui //s/1 /4 ABSSV

&Nisei Snip — 3 laquo0 /guano

0 a.

0 Cl..

0 a.

ad

0 a.

0 a.

0 a.

0 a.

ad

sol;nadeuatii ig Z AlSolooew.telid

0 ()- I? R P

D 0

o. 0 a.

0 a.

0 a.

0 am

BALI/A v svom 'an s dezw

a 0 E a a o

a. 0 a.

a 09

PR

OG

RA

M O

UT

CO

ME

S

Ab

ility

to

en

gage

in li

felo

ng

lea

rnin

g a

nd

und

ers

tand

ing of

the

ne

ed to k

ee

p a

bre

ast

of th

e d

eve

lopm

ent

s in

th

e

speci

fic fi

eld

of

pract

ice

A

bili

ty to

de

mo

nst

rate

eff

ect

ive

com

muni

catio

n a

nd

faci

litat

ion

ski

lls o

rally

and

in w

ritin

g u

sing

bot

h E

ngl

ish

and

Fili

pino

Ab

ility

to

wo

rk e

ffe

ctiv

ely

and

indepe

nden

tly in

multi

-dis

cipl

ina

ry a

nd

mul

ti-cu

ltura

l tea

ms

A r

ecog

niti

on o

f pro

fess

ion

al, s

oci

al, a

nd e

thic

al

resp

onsi

bili

ty

An

appr

eci

atio

n of "F

ilipi

no h

isto

rica

l and

cul

tura

l her

itage

" (b

ase

d o

n R

A 7

722)

A

bili

ty to

pra

ctic

e p

harm

acy

in a

pro

fess

iona

l and

eth

ical

ma

nn

er

Abi li

ty to

pro

vide p

har

mac

eutic

al c

are

Abili

ty to

cond

uct

re

leva

nt r

esea

rch a

nd d

isse

min

ate

find

ings

Ab

ility

to

ap

ply

man

age

ment

& e

ntre

preneur

ial s

kills

U) a. cc 0

ABoiodanouy 19 A6opo3o9

a ci-

0 a. 0 A. 0

a.

ad

E d

R c1-

dp.is -.ifieuarclariu3 pue 5urievevi

Li R. R R. e R

0 PD

a.

ad

a.

A6oloorxo± Immo

a 0-

0 a. a 0. a a.

ad

a a. 0 11.

P u.

a 0-

so I 419 "a sousprodspn r 100)ineoeurielid

E. a.a_ 0 0 a.

ad El E a. a.

uor4rmisuo0 is, Ajo;s!H euiddriNd cl" a-

ad

0 ad a.

PR

OG

RA

M O

UT

CO

MES

Abi

lity

to e

ngag

e in

life

long

lear

ning

and

und

erst

and i

ng of

the

need

to k

eep

abre

ast o

f the

dev

elop

men

ts in

the

spec

ific

field

of p

ract

ice

Ab i

lity

to d

emon

stra

te e

ffect

ive

com

mun

icat

ion

and

faci

litat

ion

skill

s or

ally

and

in w

ritin

g us

ing

both

Eng

lish

and

Filip

ino

Abi

lity

to w

ork

effe

ctiv

ely

and in

depe

nden

tly in

mul

ti-di

scip

linar

y an

d m

ulti-

cultu

ral t

eam

s A

reco

gniti

on o

f pro

fess

iona

l, soc

ial, a

nd e

thic

al

resp

onsi

bilit

y A

n ap

prec

iatio

n of "F

ilip i

no h

isto

rical a

nd c

ultu

ral h

erit

age"

(b

ased

on

RA

No.

772

2)

Abi

lity

to p

ract

ice

phar

mac

y in

a p

rofe

ssio

nal a

nd e

thic

al

man

ner

A

bili ty

to p

rovi

de p

harm

aceu

tical

car

e A

bilit

y to

con

duct

rele

vant

rese

arch

and

dis

sem

inat

e fin

ding

s

Abi

lity

to a

pply

man

agem

ent &

ent

repr

eneu

rial s

kills

.4

a)

0_ 6-

c o

co

co • 0

ai •S -o c

00 „, a)

(ati C

in V a) • c co

fi C C

E 3 '0 -0 2 73 ••-• I-• CD

2

CD 112 E ca a) c en co 2 c) E

°• 8 E 45 E

in 0 5 2 41) E ° a (a E C'." b.

re 'a & Q. 'i2 e as: II Cu 0 ts a) -0 — 0 CO 46 c c tr. o 0° E c =

I I -JICP 11.

0.;

Sam

ple

Curr

icul

um

Del

iver

y M

eth

ods

_x 8 3 -8

12 8 sr (1) a a- n 't _c c, t co

I, 4., '... id " 2 C t C) ..4.... al C a' CD a.) ....c:?. 2 .-.... (a);

o 0 c° co ca 0 -(15 f2 (0 ,,c.

Eo3 _ o -67,.. C La ..... _0 t- 0 "0 --0 :-= -7 4-1, o E .:.-a al E

'6

L Lri 12 ci situ To -0 C CU c c ui 0 o 0 a"

co) 0 c.

(I) c- ) To .....• (..) _a p ..- 0 -T c) .•-• 0 0 ti ea 0 t "0 C •-• -0 a 0) to 1.0 ..0 to C.) 0 L /.. al 0 a: to x 1- 0 in -1 a a c3 CU D

iii tri 5 CL '0 ® C C u j .0 45 g ..... as o

fierf E!, _ , . .. . . . . Eua : )1 .1

-. co c '''a 2- a '5 < c _0 .- E co

"4)6 oc ti ca I:- -- —0) -6' u, c 0 'a 0 2

n .0) al t c ta _c co w -0 0 I- -0 2 0 xj-

0 a) - 0 E 0 :Cr6 2 co la" 0 '... CL 0 _n 2 4-; -_ _c

5 oc 2 Ea ) 70 E el 2 RC 76°

c -c. i 2 8 ,t9 0 0 0)i 51 8 .3-E la a. .N ..c ."Z-01

5 r2 cin :---, '5 ... a)•-• m !._-, a co E 5 To .0 c I- ,}g. ci; 0 c C Z a) c 76- ‹ E co -61 2 a.

0 -I 111 u)

E •Ei .() it 'Si 0 _ c; O. 0 X < X 111 C•i

E < oi , 4

-a w -c-i Wta

cp C -C C 0

.QE ?,05

c t E = .0 c 0 CD

t -0

tr 2 t co

c

S.- o

co W E

-c .g" ES W

.5 a ED a a 2 -{2 0 -0 c

c 43)

8 .0

js 8E00 0 las F- - m

Ct th

E .c

.0 C°

tm a.

a. W)

co c.)

In m

c c a) 8 8 0 0 o

E E

0 0 co c o .V

C C.) 0 -0 a.

Sam

ple

Cours

e S

ylla

bus

& In

stru

ctio

na

l Des

ign

Pre

-requ

isite

s: P

harm

aceu

tical

Bio

chem

istr

y

Cou

rse

Cre

dit

4 u

nits

(2

hour

s le

ctur

e, 6

hour

s la

bora

tory

)

Co

-re

quis

ites:

Hum

an P

hysi

olog

y and

Pat

hoph

ysio

logy

u) -o C a3 46 -E c.

a) a) 5 E E .44C To a o

8 (D> E — -4-4 2 C) w o...cO .c -0

a) 2

y _c as 12 .c a) iii tii ;60 IQ € g g a >, u) a) o a) -E ° a u) 5)) .2 M o a, >-. o) 2 8 ,0 13 . c- To- o o c E

c a

Ec cn •C- E t). ° m

..11-3 we) a ta E e 8 0 y c To c To - co

c '47..>-C 0 8 0 7

0 t/L8 — — -0 ., c c .c c 0 0 0) El. 0 Cl) -5 CO • - . 2 al

:•-• To " c co 2 5 • o in 13 o co ..• co ...-• E .-

.c 0 -5 a) o 2-) co g co .2 9? a U 2 m z it, E -8 rat a ••-• -c CD 0 m" m E g .....

c 0 a) Cl) .il-. 5 .... ..- CL M (0 8 g .±Z!) 137° .

c

z2M _c€ ›..

a C :C 0 M :CC cr •-• E 6 a) -0 b 03 w .c -§ >:. ." C 13) c -- a) 2 -c — 0 0 m 2 menu>, o) o = .c ,_ = a a) 0, o co 8 .... c _ :.,_0 T 0 c -- >... mwr---0 E c- gtmgre— u) 8 0- to E

'a E h. Ts 0 it $ °W a' a) a (71 4 € 86 ;di T.). — v = -8 ch ' a 2 8 a) as 13 C 0 a) c 4= To- m.-> -° g al 12 E a)

13:c :g134: ;IC' I la ..:571:12 .ct. l'ana:CC 13 ;1!I-

. - • • (1) 0

.... MI ..0 c -•••• 0 Leg 0) •r_ c 0 it) 0 0 2' g ..' t) *-7- • C ° 0 t-io, , gi ur 5-8 g U) g 0 01 ? r‘ 0 2 w 0) o 0 0 0 a oi — a) •

.6 ci -ci ai .... oic ceis c •- •- E

No

.of

ho

urs

C .o)

1 cr (C.

Stu

den

t

asse

ssm

ent

C 0

E - ai A' CO CO 0 X I— €1 I.L.1 Q CC

•

c C 0 0 P Ca- E b La-) -8 ,E-•;?; CO CO a CD — x 0) ay $-- CD 41 CC a 0

• •

c 0

mm X 1-• 0 41 0 CC

•

Res

our

ces

nee

ded

Pow

erpo

int s

lides

LC

D P

roj e

ctor

(0 C0 a) c :0 1,- 2 0

> TA Li c a)

I— >, it 0_ v :0 2 .22 a 3% § o 5 •-• 465 > co > 00

CI .2 to 0 —di 1— 4 .-J

• • • •

Stu

dy o

utlin

e/

Gui

de q

uest

ions

fo

r re

adin

g a

ssig

nmen

t P

ower

poin

t slid

es

LC

D Pro

ject

or

AM

R P

ledg

e

form

s

Tea

chin

g-le

arni

ng

act i

vit ie

s

Dis

cuss

ion

Qui

z ga

me

on

the

his

tory

of

mic

robi

o log

y

C) 6 a .-C. 2. a x 0 fl. ch c• sar, 0 = E 5 2 t?) trocc0

• •

Dis

cuss

ion

Ant

imic

robi

a l

Res

ista

nce

pled

ging

ac

tivity

Co

nten

t ( L

ectu

re)

I.

Intr

oduc

tion

Sco

pe of M

icro

bio l

ogy

Evo

lutio

n/D

evel

opm

ent

of M

icro

b iol

ogy

II.

Prin

cipl

es of D

isea

se

and

Epi

dem

iolo

gy

Prin

cipl

es of D

isea

se

Mic

robi

a l

Mec

hani

sms

of P

atho

geni

city

Im

mun

olog

y an

d

Vac

cino

logy

/lmm

uniz

ati

on T

ech

niqu

es

Ill.

Prin

cipl

es of A

nti-

bact

erial

Che

mot

hera

py

Ant

i-bac

terial

Age

nts

Mic

robi

a l

Res

ista

nce

Lea

rnin

g o

bj e

ctiv

es

1. R

ela

te k

ey e

vent

s an

d

cont

ribu

tions

of

imp o

rtant hi

s toric

al

pers

onal

it ies

in

mic

robi

o log

y w

ith th

e de

velo

p men

t of its

cu

rren

t med

ical

pra

ctic

e an

d a

..lic

atio

ns. _

Rel

ate

mic

rob

ial

mec

hani

sms

of

path

oge

nic i

ty to

the

ch

arac

teris

tics

of

infe

ctio

us d

isea

ses.

Des

c rib

e ho

st de

fens

e m

echa

nism

s an

d its

im

porta

nce

in the

deve

lopm

ent o

f in

fect

ious

dis

ease

s.

Just

ify th

e ch

oice

of

appr

opria

te

anti

mic

robi

a l a

gent

s

base

d o n

th

e pr

inci

ples

of a

ntim

icro

bial

sele

ctio

n.

o 4,- ccr czr wr

C oo

m as 0 X ,- (11) u..1 0 cc •

c

12 0) ill 0 CC

•

c o

m m

xn) I-, ocj LLI 0 CC

•

c o

E '@ t;

P ' 0 cc •

. a) c. -8

cv 70 8 -5

c fi- et . s 5 4- ---; — "g

a) .5 .5 '" (9 2 co ? w

7 cz. I- >, 17 =, c C 0 0 •03 a v.5 aco cv co re) •= €n _ as o 0 C./) -_-- cr ,_ M C) C) CL -J

• • • •

Stu

dy o

utlin

e/

Gui

de q

uest

ions

fo

r rea

ding

as

sign

men

t Q

uiz

que

stio

ns

Cas

es

Pow

erpo

int s

lides

LC

D Proje

cto

r

Stu

dy o

utlin

e/

Gui

de q

uest

ions

fo

r rea

ding

as

sign

men

t Q

uiz

que

stio

ns

Cas

es

Pow

erpo

int s

lides

LC

D P

roje

ctor

Stu

dy o

utlin

e/

Gui

de q

uest

ions

fo

r rea

din

g as

sign

men

t

.0

a. c c. T. .0 2

a m 1,

& b 2

( n = -5 a CL 35 "A 0 E c

.

Indi

vidu

al p

re-

quiz

D

iscu

ssio

n w

ith

sam

ple

cas

es

Indi

vidu

al p

re-

qui

z D

iscu

ssio

n w

ith

sam

ple

case

s

Indi

vidu

al p

re-

qui

z D

iscu

ssio

n w

ith

sam

.le

cas

es

C.. ,a '2 ti CC!) f2 (13

V C C 0 16 F- Co

tim Z 8 1". CO 0 C c e, m -

".=

cn o cn 0 cn u .91 cn .C. 0 •E l'a roc Etics acia$2cc'sco—T-- .2 co.,._ocoa•soo7 "t0 2 w 0 o

ci 7 mEturzEoSooSocm2

: Ili ci 6 ui u.: (.5 >:

II V

. P

rinci

ples

of A

nti-f

unga

l C

hem

othe

rapy

I V

I. F

ungal

Infe

ctio

ns

Sup

erfi

c ial

Infe

ctio

ns

Cut

aneo

us In

fect

ions

I

C Sub

cuta

neou

s In

fect

ions

I

D.

Sys

tem

ic F

unga

l In

fect

ions

VII.

V

iruse

s S

truc

ture

and

C

lass

ifica

tion

Vira

l Rep

licat

ion

Ant

i-vira

l Age

nts

Clin

ical

ly Im

porta

nt

Viru

ses

DN

A V

iruse

s R

NA

Viru

ses

I IX.

Par

asito

logy

P

roto

zoal

Infe

ctio

ns

Hel

min

thia

sis

ca e o 76 0 15 Tif la RI "c To cp •sa cri t :a pb '0a . e -0c 0 v c w a) c lw bcmcc

.E- 0 c LI 8% .4 cat° c 4.-1.6 t- 2c a) c co g c a 1— o U) a) It-. .0 (I) CD 4-• 03 CO 10 0 c C CCL,,,,,= .50 0 00a0. t-0Calt w :E. ,.-.„ a) m co - c .1-3 CO 13 E .7 0. 0 0. ca.3 co tri co

Nu

mb

er

of

ho

urs

@ t "5 1.0 0

la

a)NJ- E 0.) •

L.0 0 r Ur. S r E 0

o

$ gi in la S t a) in --• 7 tn- c.)

C 0 a) t c c co

-c 2 o 0 cti,__ •E- r.r.c,1-occt co.c in gal- -0 C

Stu

dent

as

se

ss

me

nt

... C g? 0 0 €0

D a) ..2 2 s cc 5 e co

8 w *-= -.- 0 a) c o g? k- 0

ill5 I! 11

_1

4 _c) .2 2;

coa)0_00 a as s Dun o 2

Reso

urc

es

n

eed

ed

g • 0 '-, u. m" St. Z T:1,-, 61 0 ,.. r. 4- 0 a) -0 - ca Emma 000-0c20. 0 m a in 3a8 0,020Ebt-o- coa

15 •—ti CD 0 -0 0 " 2 "g a) a) a- ._ .... — c .— — CD >'• •-•1

in u) _c C 6.• a -0 • § . it'- io 0 0 • >, e) '"" tra w < CV 4) E 2 ail .2 IP. a) • :o c

2 E 006E 0) 0 -0 • ca. (7) g 0 o 45 75-E c ra 8 0 8- E ''- 0 33a8E=20m7LT,

Teac

hin

g-le

arn

ing

a

ctiv

itie

s

>. % 72 co tl: 0 6 CO 44 § wE

0- 0 o 0 (43 t. 8 4' e b •

; 2 t - c- .0 0 z E o E lb' = •E-

0 x 0 D , -0 _1 0 w c:I as roca.

—Eo' Ec E

to (.3 c ca o •_ b

0 0 a) E (3 at a) .„0 0 .0 -2 ra) ° Cr W 0) -C •-(2 ? 4— TZ 11 II2 Z -C -a. — c t 5 -c ° E

ti ca , %1 0. -C

a) ,- o al „1/4) i_ < Li5 7 0 _p to co a) ..... • o = 2

08153gig§-0:30.E . .2

2 .0 t — 42.; 73 E 0 I- 2 0 0

tu .2 o ... Ins .... co 3 t

w o a 4c

"g

Co

nten

t (L

abo

rato

ry)

-o c

ow at >, c •th 0 a- a

0 (1) To' 0 t/ -6 & E 53 -03 150 .2 00

`-' t ett

_..:

(n No 0

15 g c la co P= •E

0 sr izo as i- 9 .7:0 i6 tura

co 0 at 0 ct 0 in a) _c •- a

o:i (5

Le

arn

ing

ob

ject

ive

s ]

al a) it

cn a) 15 -c a) E E lc _0 c

to t .92 Ea '5 .S D 0 46 a a r2 c a t -IQ -o tr) --5. co .., o I% ,-03 o

oca)— c c ° —0 a. 0 co co .5 0 w co ac 1- w 001.-.. 0-00 c 2 pn2 X C..•-•• V t_• cum 5 owa-oEoggo.E rn .7:o tr) c o ni ci

.- 0 a .2 E

a) t a) a co E , a) at tri = .2

co ••• • c 0 -ig g

mat1)(1) cti ct .6 a". -a

rtia l5 utoatE a 1-• IT 0.-C 0 -0 8 ro 63 2 ..... ID C c .5 0

E' t °-.2- 16 o. 1.2.3 0 otE bc ca a a. d 6 t ai

Leo

a)

m) ca c c a) O . I TO C ... a) E . -

„, • a 7

- m %- a W

kr) .= 4 mu ic" .9

-a c c 8 O' co .2 co 45 a) li C. .... 0) IT .-Cn 7

0

.c t _c v)

a" qj 15 a"

.F. cu

-0

2 cn

NJ 2 c: 0 5 = . 0 (1) cn

a' con) Z

id .2" i N lei .E-os .13 8 0

2.

'a 702

(/) .C) w 1-

'C C . E nr w tis ,_ ,_ CO Q i_

0_ a CO C t 0 0 .2 a) $ 'a cr) 0 o .- c - c _c

,-- .- = co a) m t 0

0 a) — • cii) a) o • > ..- 0. ca 0_,,_ L •••• 0 . > a 111 nS) a m W rE nth 0 ....7 in oC 2 ocu ..._. 8 —R

-• 0 -1G .0 0 -ro 'r. "5 a) t•-: 0 .c ,-- - a) > co - . CD cl) 0) 2 2 co 2 GC 'co a c ® b o) a...-. . m co co .2 ca co m 'Di E a .2..

to .0

135 0 • iii ? L

0 •-• ij .=--. c' Lu o S . -I

a) ca I- a)0 a) o o ,... .,.., .,- .i., o •-• c

m a) a) .7,47 . ._ .2 o ca c -0 _0

.... t -8 <, .8 .., .- 0 :r•-• 3 C M = 00 .0 •E = I.-, 150 Z7) '5 g 0 .....-e • -9 D a, Cr 0

-m):5 c .c. -2 E if -8 -c 2 2 % o iei = .

C 0() "0 L-Ca 2 E 09 ler oc 42 II-3c E nas 8 I.-8 1 ro 13 ti NI 1.1 € § g a) 8

,),i .. 0 -1 tii 2 42 > -..9.. a fill

1,-, -= 6 1 0 " -8 a) e w 0 E

xerc

ise 4

: S

impl

e

Sta

inin

g

, Le

ctu

re o

n si

mpl

e

stain

ing

• Ass

ign

mic

roor

gani

sms

per

group

Exe

rcis

e 5

: Gra

m

Sta

inin

g

Ill. In

trod

uct

ion to

B

act

erio

logy

Bact

eria

l Cel

l st

ruct

ures

B

acte

rial

Mor

phol

og

y B

acteri

al

Gen

etic

s

2. In

tegr

ate th

e fie

lds

of

bact

eriol

ogy

, virol

og

y,

myc

olo

gy,

pa

rasi

tolo

gy,

and

imm

uno

log

y as

appl

ied

in th

e tre

a tm

e nt

and

pre

ventio

n of

infe

ctio

us d

ise

ase

s.

en E cla a) in E c

E N 0 a 0 a ,

46 cn

n a) co 0 0

N.0 .0

rs E1.g1 -E . t 8 c a r . co n C a

.v) 5 g E a. c.-T 'E C- c c° a) g. 8 •as- ca al •N-, CO .....• 0 0 CO ...-.• 0 u) c = v) 5 ED. o o ••• co 0 2 o o

0-*- cm) .8 -4= 0 -„, •c - z a) f 0 .0 ..G 8 'co w ga t iu .9 0.0 00_ c co ....

vs 75 . .24 En ct 03 15 E co a u) to as ca E

E • 5 ce) c

mac o 0 cp E °2 in or€19 E! c`i •- c

a 0 o = -c a') c 0 o Emccalas 6; 0 mo cc) .. , .- 0 ,- = • ,- -c o m .....- -0 3 • E a) .2)-ii re 1:17.-cCID C a 2 8 0 0 is c• •- c cz ,.) C ta Ca a 6 - C / m i M • . C

0

e .coc E C5c ta_E (n° (722 iStm: 1.1J3/4) -C$11." CM C 21(1) .2 fa)? .17:: •-a co2 om =0....Q. co 0 .is co en - c -L,- mr, ••-• , 0.) c CY) 0 c co CD M in w .0) ' t o -0 1-• al .:3 33 0 u) - a) 0 - 48

-5 $ •-e 0 a a) 0 = 0 2 co 0 0 le as c II 0 b . 0 0 t" co a ,...• .29

.... c co zoc2 g,-.3c

. ,:„ . e.) 2 in f.. (1) a) 3 en > 'b-

mc a 2 • tr.. 0 0 .N100- 0-E 41) 1- 2 as . ca m 4- - - cn ca a2 E'Ec000wn = -- 2 mai 8 c" a) cn:43 Si -0 • n 76 •c -,7) = a a o w • -, w a) w' = To-

-6 .2 2a) .•-; -int) 6 aUmca)5oci052 mc x2.cmcga)....

. in E ca as 0 a. . o a z .2 a as -I ea .c •th* < a o) .2 "5 :•:.- unn I- I- iii 0 5

'46 c a) .- .t c 0 c C

13 E 0 a) -- i- co 1.- -2 •-• .... :::: 0 2 ..,- _ osC .0 - Mr; -EL E ig ly, 0

.N E c co . 0 co CD CD m .... _

f) 1 2 .2 :2 8' 'cf, .e5 t.9" 2 m u- S 2 2 rE. -g t„- -8 . 415 i > 1 VO t 2 g aC ° fc3 2. g 15CD 130

t 0 a t C to 15 a .g- arG a) •G 70 • E 0 ti 0- 0)-a M -g cs 0 6.u. g 4,-T, ,- e 0 CO a 5 CO " co ea -5 .c en di ...,.€° •0 - •- •D 4., ID C 3 co0c0Z _12. ,- .-6 co I- CO I- U) < (.0 0 (/) ca 0 Li- ci 0 a 8 0 Ct o T.: tr, , 0. E- < 0 ci ui 2003•=4 cci d d tii 2 2 ,i, z (..) .:e ca

-a- il)

arc m 8 w

cr Ja 2

E

s . 0 o c _ c

,- 15?-6,771 ca•-,_ 2 n® Wa- co

U XI ° cD:C5 To . - vt -0 °

in

.0- 0

-01.j art 47.2 —.E,. - o .150— N-02 oca _ , 20E0.29„

-,40--- ,-0 z 0000mo,

Cu mcq—o>..c.Cr Emm u76 070=B c0-= < t m 2 otiri ott ° Ig „c.o.. 0. WI.LoEMmi—

= *a r

eri 0 —.5

zo

0 02 1):03° wales x,w wma

,_ v 0, d id

z cn— o — Z 0 ci_ 0) •t x 22 w x .. = W . = Ili 6

.0 W 0

gp .0- ..,. wi = .._ ..?+ 5 en ,,,w w co er; —co--) 0— " Lit= 0 IS--

0 dfcci co0x70.4% =Odra zo=

oz15 OZ0 L1-1-0410 — OZZp .. co

00 to -0—.4 w W1)15 ileopon..00t.w a0 13 =0 .E °Tp0o0=0112wr r EB0Uom t-0.4,5 .0tw. wwv8wowtte, x=mx0r4xcE R= J a c.....cm mxx ._ wo0w2u_Ow< i-uOmmomOwwm

.5) 45 to en 0 o ,m c m .--..- o E wow .co.c.(1, 0 0-0 —mi.2 w .Eog -0.cccrotmt_ o c Cu.--, ,R; ca 6• Ca .E. iti 0 _c m E 4, ED = tr— 76 W C) 0 — Ct 0 M CD s_ cts D _C _C M0= -500.680t

3 0 .c •-• d OcnOcCcd

= >

V ta ,_ c c a) a asp = a5246A .c ELI - gge0.03 . t - ascii s- o, D n Al -C Xflcir N-Cr•-=N000

C.--. 0) 2 0 - c4-ooz.e a'"01.6 e'.

0 =0 cie 0 nMrVLI

"0 W E-221- 31'W oEs3o= Ci. .1•4 ..c ,... = W, sioo210 0 15 13 2.5 UJ w-

Ch

arac

teri

stic

s o

f B

acte

ria

0

0 4... tc ..... -0 g, a) 0 ,_ .7 ,2 0 .,9 C _a= m 0401- , c .0 0 ... la.-. 0 k 01 =

0 it s a t a (n 0 A C 15 0: ).i g mv - 00 B woo,o ww <o N VE44 C4 CD%- F. 45 ig C ,•F =Sr" < 16 •F 04 CD N 0 tr.) tv 00 S01 0 7 OcacN.m C00 42 — 0c5 o. c=cc •00cc 0 > : v et - 0Nfl o z z d wt-oE"cit

ccd oc>-l- 0 z c0z ct0..ca.2 02 05023=oo . —440 041--

0-(2 0-1°/-000e0 WW 2 Malt2n0 0C Z,W W.C =c0.(n oZM cCD)-E,SFEtt

=2

004 0tMETOB O >) c0 C00 4- 2tra —>„4- • () °a=E25, 12C 06EMEW15 27013 0 greEt00 CiMu tliEt=0.007).0 0 m megovilv m w 0=-0 w x...m xo>cx—x—c -08x4ix...pA 00 -014 k)ecoma won Luow<wOwoo 04-wo)w.....wwW.....c 00ww<000

C 0 0 C 9 _ "6 15 '6 ),

E 1 2' .

U) ot o c - c m c .0- g 0 o) w TA -2 I-

‘... E > la .8 t.... m o $ (1)9 0 .to o t 13 0 iii c> o 1 1 0-6. v c .o. as o s E atm< -c13-No!floo2, 0 gatto*Z6anElO m cto>„ t g cithAi Ld:Oilltiii2 1k 11 oE000m=—wm om m ot O sc.ccomo>=.0,..0 0n-mxo-ccocoow8.c. dEwm<mdwd<0<tiOsmwsw2.0p.sww,gwa o

cd d •:t cd d Ci ui W am: _ 5 k

c a AI t o. z *5 -0

cZ o • .c.c•-,5 asm, C) >.1-0..6 5 ce32. 3 ea u= 2:5@>

er

. gm

e-.0 E 8Ectm ct-FLE 4.4

id co U) .... *0 a) c.) o- a) -5 o c E c r (n a '0 ei c c., 0 fa 0 en 4- ..-- en a) in 4) el • t im• v... -47, • 0 -- k m .- W 0 CD a) ti) • E x co 4..' X 0

“ re re— o (.) 0 w ch rn W 13 0 e4 = w • — — kl• ... 0 .... ••••• ai •••• CD t; Cr) a Z CI) 0

4— 13 co 113 ce) IR 0 46 w

a c >, 0 r. >. .0 it)

62 7-1 Ccac -gc °01 030 Et`s "5 0 5 c.)2 2 >. 12 i3 ' C) ra 2 . 0 T.-. 0 tri,....ii• 6 0, 0 „co •ii. aa — .0-, ...., 0. 'al co m a) F In

la • - -0 z .7) o 0 E .° 03 ° () 15 -ars ° ail E r 0 0 0 0 0 —0 N C4 X .- 41' CD > U) fa x 0 ci) N mr In 2 " c c LU " 4— 0) L. ' - E ..,. a) ca 0 7•7 ra a) 2.w 3... 4) 0 412 o..v

4E 42 E (pc E a 'ounaurEoc3(aoii:- 00 -0. 000 0 o o x •-• .c E' d 2 -0 .._ -0 4.• o as 0 a) -0 x 4... 5 0 >.. c E 4- -C 0 UOUW:10. a.zboo oo oi-mP.cnow ocnct.00 cop 00...1

>,ca >, u) ,Q3 _0 CI CL c13 0 I:73 4- 0 c&. CY) C146 c E r ° 2 E 'UO 2 ° 0 00 5.11110

a) -5 ti) E-..r. U) -4= 0_ U) 3 -7-9 151-t cp ticES2 0E -- 0 oroca000'--0 -22i-c..nra co 32 .1r a ti .1= < 0_ en-

0 ± -•

ANNEX F

List of Laboratory Equipment/Facilities/Supplies

I. List of basic glassware/supplies: (at least 'I for every 5 students)

Beakers (50, 100, 250, 500 and 1,000 ml) Buret (acid and alkali) Erlenmeyer flask (100, 250, 500 ml) Florence Flask (50, 100, 250, 500 ml) Graduated cylinder (50, 100, 250, 500 and 1,000 ml) Conical flask Volumetric flask (10, 50, 100, 250, 500 and 1,000 ml) Evaporating dish Spot plate Watch glass Test tubes Test tube rack Test tube Holders Test tube brush

0. Stirring rod/glass rods Glass funnels Percolators Porcelain crucibles Pipets (transfer and measuring)/Micropipets Separatory funnels Spatula, steel and porcelain Wire gauze Iron stand Clay triangle/crucible tong/holders Buret holder Distillation set up (simple, steam and fractional)

AA.Mortar and pestle (porcelain and glass) BB.Petri dish (glass)

Others: (consumables) Filter paper L. Reagent bottles Disposable syringes and needles M. Prepared plates (TLC) Test kits N. Disposable sterile petri Disposable gloves dishes Kim wipes Parafilm pH paper Litmus paper Capillary tubes Aspirators/rubber Disposable pipets

List of Laboratory Equipment

A. Priority Equipment (for various laboratory courses) (minimum requirement):

1. Balances: Analytical balances (at least four) Top loading balance (at least two) Double beam balance (at least two) Weighing scales (at least three)

2. HPLC 3. FTIR 4. pH meter (at least two) 5. Refractometer 6. Polarimeter 7. Melting point apparatus 8. UVNis spectrometer 9. Dissolution Apparatus (at least 6 baskets/paddles) 10. Disintegration Apparatus 11. Furnace 12. Rotary evaporator 13. Microscopes, compound with LED light (at least 1 for every 5 students) 14. Fume hood (at least 1 in the Pharmaceutical Chemistry laboratory) 15. Lyophilizer/freeze drier 16. Vortex mixer (at least two) 17. Autoclave / Sterilizer with pressure gauge 18. Ovens

Drying ovens (at least two) Circulating oven Stability oven (with temperature & RH gauge) Microwave

19. Viscometer 20. Moisture Analyzer! Moisture determination instrument 21. Distilling apparatus 22. Pump (suction/vacuum) 23. Ultrasonic bath 24. Waterbath 25. Oil bath 26. Refrigerator 27. Microplate reader 28. Filtration assembly with pump 29. Centrifuge

Centrifuge, ordinary Refrigerated centrifuge

B. Additional equipment for specific courses

1. PHYSICAL PHARMACY & Quality Assurance

a. Specific gravity determination Hydrometers Pycnometer

b. Soxhlet Apparatus c. Hardness Testers d. Buret (acid/alkali) e. Percolators

Page 46 of 49 lerilars,„

Porcelain crucibles Calipers Friabilator Tensiometer Hygrometers Assembly for chromatographic methods (CC, PC, TLC)

I. UV plate reader

2 PHARMACEUTICAL DOSAGE FORMS, Pharmaceutical Manufacturing, & Cosmetics Product Development

Stirrers (glass, magnetic) Filter assembly Blenders mortar and pestle Tablet machine/Compression machine (multi-station) Pill tile Capsule filler Encapsulating machine Powder Sieves, various mesh sizes Crimper Suppository mold

I. Mixing container (stainless)

m Funnels (glass)

n. Filling apparatus

Granulator Coating pan Mixing bowl Ointment slab Powder mixer (V or sigma blade) Homogenizer Bench for crossing over (boundary for dirty & clean rooms)

gowning area and washroom

w lipstick mold moisture determination

balance viscometer pressing machine for compact powders, blush & eye shadows

3. MEDICINAL CHEMISTRY/ PHARMACOGNOSY / PHARMACEUTICAL BOTANY/RESEARCH

Soxhlet apparatus Distilling unit Water Deionizer Percolators Thin Layer Chromatograph Clevenger Apparatus

9- Separatory Funnels

h. Metabolic Cage Set of prepared slides for Botany

I. Bell jar

Page 47 of 49

4. PHARMACEUTICAL BIOCHEMISTRY

a Simple Distillation Setup b Separatory funnel c Burner d Electric hot plates/stoves e Mortar and pestle f. Iron clamp g Conductivity apparatus h Magnetic stirrer and spin bars I. Urinometer j. Capillary tubes k Spot plates

6. MICROBIOLOGY AND PARASITOLOGY

a. Refrigerators Regular -20 to -40 degrees centigrade refrigerator

b. Colony counter c. Inoculating chamber/Laminar Flowhood d. Inoculating needles and loops (at least 10) e. Microscopes (with 3 objectives, LPO, HP0 and 010) f. Pipets, 1 mL, 5mL, 10 mL/or pipetors (at least 5 each) g. Petri dishes (at least 50) h. Test tubes, 3 in and 6 in i. Incubator j. Autoclave/Steam sterilizer (with pressure gauge) k. Steam bath/water bath

6. PHARMACOLOGY, TOXICOLOGY, HUMAN PHYSIOLOGY & PATHOPHYSIOLOGY

Animal Cage Sphygmomanometer Stethoscope • Anatomical models Hand lens Glucometer Oral gastric gavage tube Rectal/Oral/Digital Thermometer Metabolic cage

Vernier Caliper Rota-ros treadmill for mouse

I. Grip-strength meter for mice/rat Analgesimeter Sets of prepared slides for Anatomy Sharps container for used needles for injection Injection sets (syringe with needle for SC and IM administration of vaccines/NSS) Powder-free gloves Emergency kit in vaccine administration

III. ADDITIONAL Laboratory Facilities

Medicinal plant garden (local medicinal plants labeled with complete scientific names & medicinal use/s) Science Interface Workshop Controlled room (air-conditioned) Biological safety cabinet (at least Class Ill) Animal house/laboratory facility (IACUC-compliant) Pharmaceutical pilot manufacturing facility (CGMP compliant) Cosmetics product development facility Instruments room (for sensitive instruments & equipment, eg, HPLC, analytical balances, etc)

For research purposes when needed:

Plantar apparatus Plethysmometer Mechanical shaker Dissecting sets Micropipets of various capacities (with tips) Rotary evaporator

0. Lyophilizer/Freeze-dryer Biorefrigerator Densitometer Scanning electron microscope (SEM) LC-MS

Page 49 of 49

Documents

High6.1.2, OFFICE OF THE PRESIDENT ..o C #OFFICIAL'ik